News & events Upcoming events 54th JBP - Journées de Biologie Praticienne Dec 4, 2020 - Dec 5, 2020 Paris , France More info and meet us there Les Jeudis de Fleurus Dec 17, 2020 - Dec 17, 2020 Montignies-sur-Sambre, Charleroi , Belgium More info and meet us there See all upcoming events Latest news Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin Jul 1, 2020 Fujirebio Europe announces the release of the Lumipulse G Aldosterone and Renin assays for the fully automated quantitative determination of... Read more iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked May 12, 2020 Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been... Read more Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Apr 24, 2020 Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma... Read more Load More
54th JBP - Journées de Biologie Praticienne Dec 4, 2020 - Dec 5, 2020 Paris , France More info and meet us there
Les Jeudis de Fleurus Dec 17, 2020 - Dec 17, 2020 Montignies-sur-Sambre, Charleroi , Belgium More info and meet us there
Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more
Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more
Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more
Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin Jul 1, 2020 Fujirebio Europe announces the release of the Lumipulse G Aldosterone and Renin assays for the fully automated quantitative determination of... Read more
iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked May 12, 2020 Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been... Read more
Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Apr 24, 2020 Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma... Read more
